Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1989-08-03
1990-08-21
Wax, Robert A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514263, 544267, 260403, A61K 3152, A61K 31715
Patent
active
049506544
ABSTRACT:
A hydrophilic theophylline powder formulation consisting of
REFERENCES:
patent: 4117132 (1976-06-01), Seebach
patent: 4141986 (1979-02-01), Cassidy et al.
patent: 4632822 (1986-12-01), Peters et al.
patent: 4707481 (1987-11-01), Amschler et al.
patent: 4732901 (1988-03-01), Buckle
patent: 4755525 (1988-07-01), Markwell et al.
Chemical Abstracts, Band 109, Nr. 22, Nov. 28, 1988, Seite 456, Zusammenfassung Nr. 197189s, Columbus, OH, U.S. & JP-A-No. 62 286 921, Taisho Pharmaceutical Co., Ltd. 12-12-87.
Chemical & Pharmaceutical Bulletin, Band 35, No. 10, Oct. 1987, Seiten 4271-4276, Pharmaceutical Society of Japan, Tokyo, Japan; Nishihata et al.; "Use of Hydrogenated Soya Phospholipids as a Diluent".
Cur. Ther. Res., vol. 21, No. 2, 233, 1977.
Horn Dieter
Krueger Goetz
Spengler Reinhard
BASF - Aktiengesellschaft
Wax Robert A.
Webber Pamela S.
LandOfFree
Hydrophilic theophylline powder formulation and its preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydrophilic theophylline powder formulation and its preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydrophilic theophylline powder formulation and its preparation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1677780